| abstract |
The invention relates to application systems for buccal application, comprising 17α-estradiol in a dosage of 50 to 400 µg, preferably 200 to 400 µg, particularly preferably 300 µg, together with one or more pharmaceutically acceptable additives or media for implementing the treatment or minimization of hot flashes in women having estrogen deficiencies. |